Last updated on 29 Apr 2025
Owner Info
Taro Pharmaceuticals U.S.A., Inc.
3 Skyline Drive
Hawthorne, New York, 10532 UNITED STATES OF AMERICA,
Serial Number
2410714 filed on 5 Dec 2023
Correspondent
Banki Haddock Fiora
Level 22,
85 Castlereagh Street,
Sydney, NSW, 2000 AUSTRALIA
2410714
NA
NA
WORD
Status Date | Action Taken |
---|---|
29th Apr 2025 | Extension of Time Granted correspondence sent |
29th Apr 2025 | Extension of Time Granted |
29th Apr 2025 | Extension of Time Requested |
11th Nov 2024 | Adverse Report (Examination) correspondence sent |
11th Nov 2024 | IP Right has been Examined |
30th Oct 2024 | Examination Response Received |
29th Jan 2024 | Adverse Report (Examination) correspondence sent |
29th Jan 2024 | IP Right has been Examined |
8th Dec 2023 | Awaiting examination |
5th Dec 2023 | IP Right Filed correspondence sent |